Sterile Products Community

 View Only

Webinar: In vitro and in silico predictions of orally inhaled drug product in vivo performance

  • 1.  Webinar: In vitro and in silico predictions of orally inhaled drug product in vivo performance

    Community Leadership
    Posted 08-07-2023 14:47

    We invite you to participate and attend our second webinar in the series on " In vitro and in silico predictions of orally inhaled drug product in vivo performance   " on Sep 15, 2023, 11:00 am - 1:00 pm EDT. The webinar is sponsored by the Society for Pharmaceutical Dissolution Science (SPDS), US Chapter, and co-sponsored by the American Association of Pharmaceutical Scientists (AAPS) - IVRDT community.

     If you are not a member of the SPDS US Chapter yet, please register at our website at https://spds.us

    Once you are a member of the SPDS US Chapter, you can access the agenda and attend the meeting on Sep 15th.

    Topic

    In vitro and in silico predictions of an orally inhaled drug product in vivo performance 

    Time (EDT)

    Title

    Speaker/Affiliation

    11:00 am – 11:05 am

    Welcome

    Dr. Vinod Shah/Pharmaceutical Consultant

    11:05 am – 11:10 am

    Introduction of speakers/topic by the session chair

    Dr. Deanna Mudie/Lonza

    11:10 am – 11:40 pm

    The current status and considerations for dissolution testing of orally inhaled drug products (OIDPs)

    Dr. Elizabeth Bielski/Senior Pharmacologist, FDA Office of Generic Drugs

    11:40 pm – 12:10 pm

    Modeling and simulation to support the development and approval of generic orally inhaled drug products (OIDPs)

    Dr. Ross Walenga/Chemical Engineer, FDA Division of Quantitative Methods and Modeling at the Office of Research and Standards

    12:10 pm – 12:40 pm

    Incorporating complexity and disease state in pulmonary tissue models of orally inhaled drug products (OIDPs)

    Dr. James Mullin/Senior Principal Scientist, Simulations Plus

    12:40 pm -01:00 pm

    Panel Discussion. Questions and Answers

    All speakers

    Stay safe and healthy,

     On behalf of the Scientific Advisory Committee of SPDS US Chapter and AAPS IVRDT community



    ------------------------------
    Sanjaykumar Patel
    Principal Scientist
    Merck and Co Inc
    Rahway, NJ
    [email protected]

    Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
    ------------------------------